Iron-Clad Orchid (Dendrobium officinale, Tiepi Shihu) Improves Salivary Gland Function and Oral Microbiota in Nasopharyngeal Cancer Patients Undergoing Radiotherapy
Dendrobium officinale, also known as Tiepi Shihu or iron-clad orchid, has been integral to traditional Chinese medicine (TCM) for centuries. Renowned for its ability to “nourish yin,” alleviate dryness, and address inflammation, this medicinal orchid is traditionally consumed as a tea or decoction to support tissue healing and immunity. Recent research highlights its role in managing radiotherapy-induced oral mucositis (RIOM), a painful and debilitating complication of nasopharyngeal carcinoma (NPC) treatment. By improving salivary gland function, reducing inflammation, and regulating the oral microbiota, Dendrobium officinale offers an effective natural solution for RIOM.
Orchid Tea Alleviates Oral Mucositis Symptoms
A randomized clinical trial conducted at Zhejiang Cancer Hospital evaluated the therapeutic effects of Tiepi Shihu tea in 60 NPC patients undergoing radiotherapy. The trial divided patients into two groups: one received Tiepi Shihu tea alongside a vitamin B12 gargle, while the other received the gargle alone. After treatment, the orchid tea group exhibited measurable improvements in salivary function, reduced inflammation, and enhanced mucosal healing.
- Salivary Flow Restoration: Patients in the Tiepi Shihu group demonstrated a 25% improvement in salivary flow compared to the control group. This reduction in dryness alleviated discomfort, a hallmark symptom of RIOM, and improved overall oral hydration.
- Inflammation Modulation: The study reported a 30% increase in IL-10, an anti-inflammatory cytokine, in the Tiepi Shihu group. This finding underscores the orchid’s ability to suppress inflammation and promote healing in damaged oral tissues.
Reduction in Severe Mucositis: Cases of severe mucositis (grades III and IV) decreased by 40% in patients receiving Tiepi Shihu tea, highlighting its effectiveness in reducing symptom severity and accelerating recovery.
Restoring Balance to the Oral Microbiota
One of the most intriguing findings from the study was the significant shift in oral bacterial composition among patients treated with Tiepi Shihu. Beneficial bacterial genera such as Erysipelotrichales and Leptotrichiaceae increased, while inflammatory-associated pathogens were suppressed. This rebalancing of the oral microbiome contributed to a healthier environment, supporting the recovery of mucosal tissue and reducing inflammation. By directly influencing the oral flora, Dendrobium officinale helped mitigate the bacterial-driven components of RIOM.
Mechanisms Behind Salivary Gland and Mucosal Recovery
The bioactive polysaccharides in Dendrobium officinale are central to its therapeutic effects. These compounds drive several key mechanisms:
- Enhancing Salivary Gland Function: Tiepi Shihu polysaccharides stimulate aquaporin-5 (AQP-5) expression, improving water transport and salivary secretion. This effect alleviates dry mouth and restores mucosal hydration.
- Accelerating Epithelial Repair: Patients in the orchid tea group experienced a 20% increase in epithelial growth factor (EGF) levels. EGF is critical for cell proliferation and wound closure, reducing the severity of mucosal damage caused by radiotherapy.
- Immune Regulation: The study highlighted the orchid’s role in boosting IL-10 and IL-11 levels, anti-inflammatory cytokines that protect against further tissue damage and help maintain immune balance during recovery.
Bacterial Modulation: By suppressing harmful bacterial species and promoting beneficial ones, Dendrobium officinale supports a healthier oral environment, further reducing inflammatory responses and supporting sustained healing.
Applications for Nasopharyngeal Cancer Patients
RIOM is a common complication of radiotherapy, significantly impacting patient quality of life and often leading to interruptions in treatment. Symptoms such as dryness, pain, and difficulty eating or speaking can delay therapy schedules, compromising cancer care outcomes. Tiepi Shihu provides a natural, evidence-based option to address these challenges. Its dual benefits of local action on the oral mucosa and systemic immune modulation make it an ideal integrative therapy for NPC patients.
Potential for Broader Oncology Support
The success of Dendrobium officinale in managing RIOM suggests broader applications in other radiotherapy-induced complications, such as xerostomia and esophageal mucositis. Given its ability to regulate inflammatory responses, improve tissue hydration, and accelerate epithelial repair, this orchid may serve as a versatile tool in supportive oncology care. Future research should focus on refining dosing protocols and exploring its effectiveness in diverse patient populations.
Conclusion
Dendrobium officinale (Tiepi Shihu, iron-clad orchid) demonstrates significant benefits for patients experiencing radiotherapy-induced oral mucositis. By improving salivary gland function, reducing inflammation, and rebalancing the oral microbiota, this medicinal orchid provides a powerful natural option for enhancing patient care. Its proven dual action on local tissues and systemic immune responses highlights its potential as a key addition to integrative cancer treatment protocols.
Source
Yang J, Liu Y, Yao H, et al. Effect of Dendrobium officinale on radioactive oral mucositis of nasopharyngeal carcinoma and changes of oral microecology. Integr Cancer Ther. 2025;24:15347354251313524. https://doi.org/10.1177/15347354251313524
